Bio-Techne SVP exercises RSUs, shares withheld
Bio-Techne Corp senior vice president and general counsel Shane Bohnen reported routine equity compensation activity.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Bio-Techne Corp senior vice president and general counsel Shane Bohnen reported routine equity compensation activity. On April 3, 2026, he exercised restricted stock units into 2,259 shares of common stock. Of these, 740 shares were withheld at $53.13 per share to cover tax obligations, leaving him with 5,904 common shares held directly. He also continues to hold multiple stock option and restricted stock unit awards that can convert into additional Bio-Techne common shares over time.
Insider Trade Summary
2,259 shares exercised/converted
Exercise
3 txns
Insider
Bohnen Shane
Role
SVP - General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,259 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,259 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 740 | $53.13 | $39K |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Performance Restricted Stock Units | -- | -- | -- |
| Holding | Performance Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Performance Restricted Stock Units | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Performance Restricted Stock Units | -- | -- | -- |
| Holding | Restricted Stock Units | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 10,383 contracts (Direct);
Common Stock — 5,904 shares (Direct);
Stock Option (Right to Buy) — 76,375 contracts (Direct);
Performance Restricted Stock Units — 28,806 contracts (Direct);
Performance Stock Option (Right to Buy) — 12,924 contracts (Direct)
Footnotes (14)
- F1. Fully exercisable.
- F2. Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024.
- F3. Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.
- F4. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F5. 2,259 restricted stock units vest on 4/3/2026.
- F6. Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.
- F7. 49 restricted stock units vest on 8/15/2026.
- F8. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F9. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F10. 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
- F11. Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- F12. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F13. 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.
- F14. Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028.
Key Figures
RSUs converted: 2,259 shares
Tax-withheld shares: 740 shares
Share price for withholding: $53.13 per share
+5 more
8 metrics
RSUs converted
2,259 shares
Restricted Stock Units converted into common stock on April 3, 2026
Tax-withheld shares
740 shares
Shares withheld at $53.13 per share for tax obligations
Share price for withholding
$53.13 per share
Value used for 740-share tax-withholding disposition
Shares after transaction
5,904 shares
Common stock directly owned following April 3, 2026 transactions
Option position 1
8,848 shares at $47.60
Stock option right to buy common stock, expiring August 7, 2026
Option position 2
8,944 shares at $66.97
Stock option right to buy common stock, expiring August 5, 2027
Performance RSUs
13,992 units
Performance Restricted Stock Units linked to common stock
Latest option grant
17,897 shares at $53.60
Stock option right to buy common stock, expiring August 15, 2035
Key Terms
Restricted Stock Units, tax-withholding disposition, Performance Restricted Stock Units, Stock Option (Right to Buy), +1 more
5 terms
Restricted Stock Units financial
""security_title": "Restricted Stock Units""
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
""transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Performance Restricted Stock Units financial
""security_title": "Performance Restricted Stock Units""
Performance restricted stock units (PRSUs) are promises to deliver company shares to employees or executives only if the business meets specific performance targets and any time-based holding rules. Think of them as a bonus that converts into stock only after set goals are reached, so investors watch PRSUs for two reasons: they can dilute existing shares if paid out, and they signal how closely management’s pay is tied to company performance.
Stock Option (Right to Buy) financial
""security_title": "Stock Option (Right to Buy)""
derivative exercise/conversion financial
""transaction_action": "derivative exercise/conversion""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did BIO-TECHNE (TECH) report for Shane Bohnen?
BIO-TECHNE reported that SVP and general counsel Shane Bohnen exercised restricted stock units into 2,259 shares of common stock. As part of this event, 740 shares were withheld to satisfy tax obligations, and he now directly holds 5,904 common shares.
What stock options and RSUs does Shane Bohnen still hold at BIO-TECHNE (TECH)?
Shane Bohnen retains several stock options and restricted stock units. These include options with exercise prices such as $47.60, $66.97, and $120.46, and multiple performance and time-based RSU grants that together cover tens of thousands of underlying BIO-TECHNE shares.
How many BIO-TECHNE (TECH) restricted stock units vested for Shane Bohnen in this event?
The filing reports that 2,259 restricted stock units converted into an equal number of BIO-TECHNE common shares. A related footnote explains that each restricted stock unit represents a right to receive one share of common stock, and these units vested on April 3, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
